alanine has been researched along with Diabetic Retinopathy in 8 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "For the purpose, 195 subjects with type 2 diabetes with PDR were compared with 143 subjects with type 2 diabetes of duration of more than 10 years who had no clinical signs of diabetic retinopathy." | 1.35 | K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes. ( Osredkar, J; Petrovic, D; Petrovic, MG; Saraga-Babić, M, 2008) |
| "A total of 445 patients with type 2 diabetes who were enrolled in the Berlin Diabetes Mellitus Study and in whom we determined albuminuria and the presence of ESRF and retinopathy were genotyped for the PPAR-gamma2 Pro12Ala polymorphism." | 1.31 | Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. ( Brand, E; Herrmann, SM; Ringel, J; Staessen, JA; Wang, JG, 2002) |
| "Diabetic nephropathy is the most frequent cause of end-stage renal failure." | 1.31 | [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. ( Buraczyńska, M; Ksiazek, A; Ksiazek, P; Nowicka, T; Spasiewicz, D; Łopatyński, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Du, X | 3 |
| Yang, L | 3 |
| Kong, L | 3 |
| Sun, Y | 3 |
| Shen, K | 3 |
| Cai, Y | 3 |
| Sun, H | 3 |
| Zhang, B | 3 |
| Guo, S | 3 |
| Zhang, A | 3 |
| Wang, X | 3 |
| Jin, H | 1 |
| Zhu, B | 1 |
| Liu, X | 1 |
| Jin, J | 1 |
| Zou, H | 1 |
| Petrovic, MG | 1 |
| Osredkar, J | 1 |
| Saraga-Babić, M | 1 |
| Petrovic, D | 1 |
| Herrmann, SM | 1 |
| Ringel, J | 2 |
| Wang, JG | 1 |
| Staessen, JA | 1 |
| Brand, E | 1 |
| Buraczyńska, M | 1 |
| Ksiazek, P | 1 |
| Łopatyński, J | 1 |
| Spasiewicz, D | 1 |
| Nowicka, T | 1 |
| Ksiazek, A | 1 |
| Al-Kateb, H | 1 |
| Boright, AP | 1 |
| Mirea, L | 1 |
| Xie, X | 1 |
| Sutradhar, R | 1 |
| Mowjoodi, A | 1 |
| Bharaj, B | 1 |
| Liu, M | 1 |
| Bucksa, JM | 1 |
| Arends, VL | 1 |
| Steffes, MW | 1 |
| Cleary, PA | 1 |
| Sun, W | 1 |
| Lachin, JM | 1 |
| Thorner, PS | 1 |
| Ho, M | 1 |
| McKnight, AJ | 1 |
| Maxwell, AP | 1 |
| Savage, DA | 1 |
| Kidd, KK | 1 |
| Kidd, JR | 1 |
| Speed, WC | 1 |
| Orchard, TJ | 1 |
| Miller, RG | 1 |
| Sun, L | 1 |
| Bull, SB | 1 |
| Paterson, AD | 1 |
| Malecki, MT | 1 |
| Cyganek, K | 1 |
| Mirkiewicz-Sieradzka, B | 1 |
| Wolkow, PP | 1 |
| Wanic, K | 1 |
| Skupien, J | 1 |
| Solnica, B | 1 |
| Sieradzki, J | 1 |
| Engeli, S | 1 |
| Distler, A | 1 |
| Sharma, AM | 1 |
1 review available for alanine and Diabetic Retinopathy
| Article | Year |
|---|---|
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
Metabolomics of various samples advancing biomarker discovery and pathogenesis elucidation for diabetic retinopathy.
Topics: Aged; Alanine; Biomarkers; Diabetes Mellitus; Diabetic Retinopathy; Glutamine; Humans; Lactates; Mid | 2022 |
1 trial available for alanine and Diabetic Retinopathy
| Article | Year |
|---|---|
Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications G
Topics: Alanine; Albuminuria; Amino Acid Substitution; Diabetic Nephropathies; Diabetic Retinopathy; Disease | 2008 |
6 other studies available for alanine and Diabetic Retinopathy
| Article | Year |
|---|---|
Metabolic characterization of diabetic retinopathy: An
Topics: Aged; Alanine; Antioxidants; Aqueous Humor; Area Under Curve; Aspartic Acid; Cataract; Diabetic Reti | 2019 |
K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes.
Topics: Aged; Alanine; Case-Control Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Re | 2008 |
Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
Topics: Alanine; Amino Acid Substitution; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Nephropathies | 2002 |
[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
Topics: Adult; Alanine; Alleles; Angiotensinogen; Case-Control Studies; Cysteine; Diabetes Mellitus, Type 2; | 2002 |
Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes.
Topics: Aged; Alanine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Genotype; Humans; Male; Midd | 2008 |
Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
Topics: Adult; Alanine; Amino Acid Substitution; Cholesterol; Codon; Coronary Disease; Diabetes Mellitus; Di | 1999 |